Taaleri Bioindustry has invested in Finnish Food Factory, a company that produces plant-based dairy products.
Contentlockr
Helsinki-based Taaleri Bioindustry, a Nordic investment and asset manager, announced that Taaleri Bioindustry Fund I has invested €10M in Finnish Food Factory.
Finnish Food Factory is a contract manufacturer of plant-based dairy products. The company develops and produces a range of drinks, cooking products and snacks, working in collaboration with its customers. Its operations are built on contract manufacturing and joint innovation, with a focus on oat-based and other plant-based ingredients.
The company partners with customers to deliver products on agreed terms and has experience working with leading companies in the field. Its production methods enable long shelf life for products while maintaining functionality and taste.
Finnish Food Factory produces plant-based dairy alternatives for global and Nordic brands, including Fazer. The company’s turnover increased from €1.2M in 2020 to €13.5M in 2024, supported by a broad customer base and its capacity to deliver products on schedule.
Capital utilisation
The investment marks Taaleri Bioindustry Fund I’s sixth investment. The fund has raised over €100M in commitments, of which about half has been deployed.
Taaleri Bioindustry plans to use the funds to expand production capabilities and extend its market presence. As an Article 9 fund, Taaleri Bioindustry Fund I supports the shift towards plant-based dairy production, which has a lower carbon footprint compared to cow’s milk.
Marjatta Rytömaa, MD at Taaleri Bioindustry, says, “We are pleased to begin our collaboration with Finnish Food Factory. With its experienced team, the company has achieved successful growth in both local and international markets while consistently delivering reliable production and value-add to its global customers.”
Tuomas Kukkonen, Chair of the Board at Finnish Food Factory, adds, “Finnish raw materials – particularly oats – have become a staple in consumers’ diets. With many years of expertise in plant-based products, the cornerstone of our operations is efficient, innovative and reliable production. We are excited to welcome Taaleri Bioindustry as our growth partner.”
Brief about Taaleri Bioindustry
Founded in 2007, Taaleri Bioindustry focuses on investments in the development and industrial-scale production of bio-based materials.
Its portfolio includes scale-ups and industrial-scale projects in the bioeconomy and circular economy markets. The firm has invested in the bioindustry for several years and claims to be among the first private equity owner-operators in the Finnish bioindustry market.
Taaleri Bioindustry is part of Taaleri Group, which operates in investments, private asset management and non-life insurance. Taaleri manages €2.7B in private equity funds, co-investments and single-asset vehicles.
The group employs about 130 people, and Taaleri Plc is listed on Nasdaq Helsinki.
